speb/financial-data huggingface dataset:
DRX.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 239400000.00
DRX.L income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 239400000.00
DRX.L income_statement (annual, 2022-12-31) — Depreciation Income Statement: 208000000.00
DRX.L balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 674700000.00
DRX.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 414400000.00
DRX.L income_statement (annual, 2022-12-31) — Diluted EPS: 0.21
DRX.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 85100000.00
DRX.L income_statement (annual, 2022-12-31) — EBIT: 154600000.00
DRX.L income_statement (annual, 2022-12-31) — EBITDA: 394000000.00
DRX.L cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 5500000.00
DRX.L cash_flow (annual, 2022-12-31) — End Cash Position: 238000000.00
DRX.L balance_sheet (annual, 2022-12-31) — Financial Assets: 361000000.00
DRX.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: -111900000.00
DRX.L balance_sheet (annual, 2022-12-31) — Finished Goods: 294500000.00
DRX.L cash_flow (annual, 2022-12-31) — Free Cash Flow: 33000000.00
DRX.L cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 288700000.00
DRX.L cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
DRX.L cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 5500000.00
DRX.L balance_sheet (annual, 2022-12-31) — Goodwill: 424200000.00
DRX.L balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 566500000.00
DRX.L balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 337500000.00
DRX.L balance_sheet (annual, 2022-12-31) — Gross PPE: 4449600000.00
DRX.L income_statement (annual, 2022-12-31) — Gross Profit: 1023300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 396900000.00
DRX.L income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 41500000.00
DRX.L income_statement (annual, 2022-12-31) — Interest Expense: 76500000.00
DRX.L income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 76500000.00
DRX.L income_statement (annual, 2022-12-31) — Interest Income: 4300000.00
DRX.L income_statement (annual, 2022-12-31) — Interest Income Non Operating: 4300000.00
DRX.L cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -77200000.00
DRX.L cash_flow (annual, 2022-12-31) — Interest Received Cfo: 3300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Inventory: 348100000.00
DRX.L balance_sheet (annual, 2022-12-31) — Invested Capital: 2751700000.00
DRX.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: -180700000.00
DRX.L cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 1200000.00
DRX.L cash_flow (annual, 2022-12-31) — Issuance Of Debt: 188500000.00
DRX.L balance_sheet (annual, 2022-12-31) — Land And Improvements: 503300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 130400000.00
DRX.L balance_sheet (annual, 2022-12-31) — Long Term Debt: 1396600000.00
DRX.L balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1527000000.00
DRX.L cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 188500000.00
DRX.L cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -186400000.00
DRX.L balance_sheet (annual, 2022-12-31) — Long Term Provisions: 58600000.00
DRX.L balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 3607000000.00
DRX.L balance_sheet (annual, 2022-12-31) — Minority Interest: 13400000.00
DRX.L income_statement (annual, 2022-12-31) — Minority Interests: 2600000.00
DRX.L cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -7600000.00
DRX.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 1200000.00
DRX.L balance_sheet (annual, 2022-12-31) — Net Debt: 1202900000.00
DRX.L cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -2200000.00
DRX.L income_statement (annual, 2022-12-31) — Net Income: 85100000.00
DRX.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 85100000.00
DRX.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 82500000.00
DRX.L income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
DRX.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 85100000.00
DRX.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 85100000.00
DRX.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 82500000.00
DRX.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 82500000.00
DRX.L cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -10800000.00
DRX.L income_statement (annual, 2022-12-31) — Net Interest Income: -78800000.00
DRX.L cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 2100000.00
DRX.L cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 2100000.00
DRX.L income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -78800000.00
DRX.L cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -18300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Net PPE: 2526300000.00
DRX.L cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -162300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 744300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 37300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 141600000.00
DRX.L income_statement (annual, 2022-12-31) — Normalized EBITDA: 483500000.00
DRX.L income_statement (annual, 2022-12-31) — Normalized Income: 157595000.00
DRX.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: 207700000.00
DRX.L income_statement (annual, 2022-12-31) — Operating Income: 241100000.00
DRX.L income_statement (annual, 2022-12-31) — Operating Revenue: 7775300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 401031196.00
DRX.L balance_sheet (annual, 2022-12-31) — Other Current Assets: 187800000.00
DRX.L balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 142300000.00
DRX.L cash_flow (annual, 2022-12-31) — Other Non Cash Items: 79100000.00
DRX.L income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -5800000.00
DRX.L income_statement (annual, 2022-12-31) — Other Operating Expenses: 293900000.00
DRX.L balance_sheet (annual, 2022-12-31) — Other Payable: 351000000.00
DRX.L balance_sheet (annual, 2022-12-31) — Other Receivables: 822700000.00
DRX.L income_statement (annual, 2022-12-31) — Other Special Charges: 400000.00
DRX.L income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
DRX.L balance_sheet (annual, 2022-12-31) — Payables: 527200000.00
DRX.L balance_sheet (annual, 2022-12-31) — Prepaid Assets: 127700000.00
DRX.L income_statement (annual, 2022-12-31) — Pretax Income: 78100000.00
DRX.L balance_sheet (annual, 2022-12-31) — Properties: 0.00
DRX.L cash_flow (annual, 2022-12-31) — Purchase Of Business: -7600000.00
DRX.L cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -10800000.00
DRX.L cash_flow (annual, 2022-12-31) — Purchase Of PPE: -163900000.00
DRX.L balance_sheet (annual, 2022-12-31) — Raw Materials: 53600000.00
DRX.L income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 6752000000.00
DRX.L income_statement (annual, 2022-12-31) — Reconciled Depreciation: 239400000.00
DRX.L cash_flow (annual, 2022-12-31) — Repayment Of Debt: -186400000.00
DRX.L cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
DRX.L balance_sheet (annual, 2022-12-31) — Restricted Cash: 234000000.00
DRX.L income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
DRX.L balance_sheet (annual, 2022-12-31) — Retained Earnings: 193800000.00
DRX.L cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
DRX.L cash_flow (annual, 2022-12-31) — Sale Of PPE: 1600000.00
DRX.L balance_sheet (annual, 2022-12-31) — Share Issued: 414872491.00
DRX.L income_statement (annual, 2022-12-31) — Special Income Charges: -89500000.00
DRX.L cash_flow (annual, 2022-12-31) — Stock Based Compensation: 9600000.00
DRX.L balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1310800000.00
DRX.L balance_sheet (annual, 2022-12-31) — Tangible Book Value: 744300000.00
DRX.L income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -17005000.00
DRX.L income_statement (annual, 2022-12-31) — Tax Provision: -4400000.00
DRX.L income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.19
DRX.L cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -38700000.00
DRX.L balance_sheet (annual, 2022-12-31) — Total Assets: 5934300000.00
DRX.L balance_sheet (annual, 2022-12-31) — Total Capitalization: 2707400000.00
DRX.L balance_sheet (annual, 2022-12-31) — Total Debt: 1594000000.00
DRX.L balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1324200000.00
DRX.L income_statement (annual, 2022-12-31) — Total Expenses: 7534200000.00
DRX.L balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4610100000.00
DRX.L balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 3536500000.00
DRX.L balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2401900000.00
DRX.L income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 146300000.00
DRX.L income_statement (annual, 2022-12-31) — Total Other Finance Cost: 6600000.00
DRX.L balance_sheet (annual, 2022-12-31) — Total Tax Payable: 23300000.00
DRX.L income_statement (annual, 2022-12-31) — Total Unusual Items: -89500000.00
DRX.L income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -89500000.00
DRX.L balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 13841295.00
DRX.L balance_sheet (annual, 2022-12-31) — Treasury Stock: 50400000.00
DRX.L balance_sheet (annual, 2022-12-31) — Working Capital: 189600000.00
DRX.L income_statement (annual, 2022-12-31) — Write Off: 89500000.00
DRX.L income_statement (annual, 2023-12-31) — +Operating Expense: 940500000.00
DRX.L income_statement (annual, 2023-12-31) — +Total Revenue: 7733200000.00
DRX.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 145200000.00
DRX.L balance_sheet (annual, 2023-12-31) — Accounts Receivable: 336000000.00
DRX.L balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -2099900000.00
DRX.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 442700000.00
DRX.L balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -59400000.00
DRX.L income_statement (annual, 2023-12-31) — Amortization: 29400000.00
DRX.L cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 29400000.00
DRX.L income_statement (annual, 2023-12-31) — Basic Average Shares: 393800000.00
DRX.L income_statement (annual, 2023-12-31) — Basic EPS: 1.43
DRX.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 238000000.00
DRX.L balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 38700000.00
DRX.L cash_flow (annual, 2023-12-31) — Capital Expenditure: -441100000.00
DRX.L balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 135800000.00
DRX.L balance_sheet (annual, 2023-12-31) — Capital Stock: 49100000.00
DRX.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 379500000.00
DRX.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 379500000.00
DRX.L cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -86300000.00
DRX.L balance_sheet (annual, 2023-12-31) — Cash Equivalents: 302000000.00
DRX.L balance_sheet (annual, 2023-12-31) — Cash Financial: 77500000.00
DRX.L cash_flow (annual, 2023-12-31) — Change In Inventory: 20600000.00
DRX.L cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 51000000.00
DRX.L cash_flow (annual, 2023-12-31) — Change In Payable: -30800000.00
DRX.L cash_flow (annual, 2023-12-31) — Change In Receivables: 71400000.00
DRX.L cash_flow (annual, 2023-12-31) — Change In Working Capital: 107800000.00
DRX.L cash_flow (annual, 2023-12-31) — Changes In Cash: 145900000.00
DRX.L balance_sheet (annual, 2023-12-31) — Common Stock: 49100000.00
DRX.L cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -86300000.00
DRX.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1971000000.00
DRX.L cash_flow (annual, 2023-12-31) — Common Stock Issuance: 8600000.00
DRX.L cash_flow (annual, 2023-12-31) — Common Stock Payments: -149200000.00
DRX.L balance_sheet (annual, 2023-12-31) — Construction In Progress: 656100000.00
DRX.L income_statement (annual, 2023-12-31) — Cost Of Revenue: 5779600000.00
DRX.L balance_sheet (annual, 2023-12-31) — Current Assets: 2345400000.00
DRX.L balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 25100000.00
DRX.L balance_sheet (annual, 2023-12-31) — Current Debt: 264200000.00
DRX.L balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 289300000.00
DRX.L balance_sheet (annual, 2023-12-31) — Current Liabilities: 2087700000.00
DRX.L balance_sheet (annual, 2023-12-31) — Current Provisions: 6600000.00
DRX.L cash_flow (annual, 2023-12-31) — Deferred Tax: 233500000.00
DRX.L balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 18400000.00
DRX.L cash_flow (annual, 2023-12-31) — Depreciation: 195600000.00
DRX.L cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 225000000.00
DRX.L income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 225000000.00
DRX.L income_statement (annual, 2023-12-31) — Depreciation Income Statement: 195600000.00
DRX.L balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 306600000.00
DRX.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 403100000.00
DRX.L income_statement (annual, 2023-12-31) — Diluted EPS: 1.40
DRX.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 562200000.00
DRX.L income_statement (annual, 2023-12-31) — EBIT: 911500000.00
DRX.L income_statement (annual, 2023-12-31) — EBITDA: 1136500000.00
DRX.L cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -4400000.00
DRX.L cash_flow (annual, 2023-12-31) — End Cash Position: 379500000.00
DRX.L balance_sheet (annual, 2023-12-31) — Financial Assets: 293600000.00
DRX.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: -237900000.00
DRX.L balance_sheet (annual, 2023-12-31) — Finished Goods: 266000000.00
DRX.L cash_flow (annual, 2023-12-31) — Free Cash Flow: 394500000.00
DRX.L cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -222000000.00
DRX.L cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 2600000.00
DRX.L balance_sheet (annual, 2023-12-31) — Goodwill: 416700000.00
DRX.L balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 498200000.00
DRX.L balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 395400000.00
DRX.L balance_sheet (annual, 2023-12-31) — Gross PPE: 4920900000.00
DRX.L income_statement (annual, 2023-12-31) — Gross Profit: 1953600000.00
DRX.L balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 368400000.00
DRX.L income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 70800000.00
DRX.L income_statement (annual, 2023-12-31) — Interest Expense: 115100000.00
DRX.L income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 115100000.00
DRX.L income_statement (annual, 2023-12-31) — Interest Income: 13100000.00
DRX.L income_statement (annual, 2023-12-31) — Interest Income Non Operating: 13100000.00
DRX.L cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -106100000.00
DRX.L cash_flow (annual, 2023-12-31) — Interest Received Cfo: 10700000.00
DRX.L balance_sheet (annual, 2023-12-31) — Inventory: 328400000.00
DRX.L balance_sheet (annual, 2023-12-31) — Invested Capital: 3396300000.00
DRX.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: -451800000.00
DRX.L cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 8600000.00
DRX.L cash_flow (annual, 2023-12-31) — Issuance Of Debt: 140000000.00
DRX.L balance_sheet (annual, 2023-12-31) — Land And Improvements: 494100000.00
DRX.L balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 110700000.00
DRX.L balance_sheet (annual, 2023-12-31) — Long Term Debt: 1161100000.00
DRX.L balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1271800000.00
DRX.L cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 140000000.00
DRX.L cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -125300000.00
DRX.L balance_sheet (annual, 2023-12-31) — Long Term Provisions: 72200000.00
DRX.L balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 3732000000.00
DRX.L balance_sheet (annual, 2023-12-31) — Minority Interest: 12000000.00
DRX.L income_statement (annual, 2023-12-31) — Minority Interests: 1300000.00
DRX.L cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -10700000.00
DRX.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -140600000.00
DRX.L balance_sheet (annual, 2023-12-31) — Net Debt: 1045800000.00
DRX.L cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 6200000.00
DRX.L income_statement (annual, 2023-12-31) — Net Income: 562200000.00
DRX.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 562200000.00
DRX.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 560900000.00
DRX.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 562200000.00
DRX.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 562200000.00
DRX.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 560900000.00
DRX.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 560900000.00
DRX.L cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -11300000.00
DRX.L income_statement (annual, 2023-12-31) — Net Interest Income: -102400000.00
DRX.L cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 14700000.00
DRX.L cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 14700000.00
DRX.L income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -102400000.00
DRX.L cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 100000.00
DRX.L balance_sheet (annual, 2023-12-31) — Net PPE: 2821000000.00
DRX.L cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -429800000.00
DRX.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1472800000.00
DRX.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 52900000.00
DRX.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 317100000.00
DRX.L income_statement (annual, 2023-12-31) — Normalized EBITDA: 1239800000.00
DRX.L income_statement (annual, 2023-12-31) — Normalized Income: 634923200.00
DRX.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: 835600000.00
DRX.L income_statement (annual, 2023-12-31) — Operating Income: 1016900000.00
DRX.L income_statement (annual, 2023-12-31) — Operating Revenue: 7733200000.00
DRX.L balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 384664859.00
DRX.L balance_sheet (annual, 2023-12-31) — Other Current Assets: 292200000.00
DRX.L balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 81500000.00
DRX.L cash_flow (annual, 2023-12-31) — Other Non Cash Items: 120300000.00
DRX.L income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -3800000.00
DRX.L income_statement (annual, 2023-12-31) — Other Operating Expenses: 417700000.00
DRX.L balance_sheet (annual, 2023-12-31) — Other Payable: 389600000.00
DRX.L balance_sheet (annual, 2023-12-31) — Other Receivables: 563700000.00
DRX.L income_statement (annual, 2023-12-31) — Other Special Charges: -13700000.00
DRX.L income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
DRX.L balance_sheet (annual, 2023-12-31) — Payables: 555400000.00
DRX.L balance_sheet (annual, 2023-12-31) — Prepaid Assets: 77200000.00
DRX.L income_statement (annual, 2023-12-31) — Pretax Income: 796400000.00
DRX.L balance_sheet (annual, 2023-12-31) — Properties: 0.00
DRX.L cash_flow (annual, 2023-12-31) — Purchase Of Business: -10700000.00
DRX.L cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -11300000.00
DRX.L cash_flow (annual, 2023-12-31) — Purchase Of PPE: -429800000.00
DRX.L balance_sheet (annual, 2023-12-31) — Raw Materials: 62400000.00
DRX.L income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 5779600000.00
DRX.L income_statement (annual, 2023-12-31) — Reconciled Depreciation: 225000000.00
DRX.L cash_flow (annual, 2023-12-31) — Repayment Of Debt: -125300000.00
DRX.L cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -149200000.00
DRX.L income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 18200000.00
DRX.L balance_sheet (annual, 2023-12-31) — Retained Earnings: 666400000.00
DRX.L cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
DRX.L balance_sheet (annual, 2023-12-31) — Share Issued: 424923406.00
DRX.L income_statement (annual, 2023-12-31) — Special Income Charges: -103300000.00
DRX.L cash_flow (annual, 2023-12-31) — Stock Based Compensation: 13900000.00
DRX.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1971000000.00
DRX.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1472800000.00
DRX.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -30576800.00
DRX.L income_statement (annual, 2023-12-31) — Tax Provision: 235500000.00
DRX.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.30
DRX.L cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -180000000.00
DRX.L balance_sheet (annual, 2023-12-31) — Total Assets: 6038400000.00
DRX.L balance_sheet (annual, 2023-12-31) — Total Capitalization: 3132100000.00
DRX.L balance_sheet (annual, 2023-12-31) — Total Debt: 1561100000.00
DRX.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1983000000.00
DRX.L income_statement (annual, 2023-12-31) — Total Expenses: 6716300000.00
DRX.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 4055400000.00
DRX.L balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3693000000.00
DRX.L balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1967700000.00
DRX.L income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 908200000.00
DRX.L income_statement (annual, 2023-12-31) — Total Other Finance Cost: 400000.00
DRX.L balance_sheet (annual, 2023-12-31) — Total Tax Payable: 20600000.00
DRX.L income_statement (annual, 2023-12-31) — Total Unusual Items: -103300000.00
DRX.L income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -103300000.00
DRX.L balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 40258547.00
DRX.L balance_sheet (annual, 2023-12-31) — Treasury Stock: 199600000.00
DRX.L balance_sheet (annual, 2023-12-31) — Working Capital: 257700000.00
DRX.L income_statement (annual, 2023-12-31) — Write Off: 32500000.00
DRX.L income_statement (annual, 2024-12-31) — +Operating Expense: 969700000.00
DRX.L income_statement (annual, 2024-12-31) — +Total Revenue: 6162500000.00
DRX.L balance_sheet (annual, 2024-12-31) — Accounts Payable: 1289100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1289100000.00
DRX.L balance_sheet (annual, 2024-12-31) — Accounts Receivable: 470300000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 105400000.00
DRX.L balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -2313800000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -2313800000.00
DRX.L balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 445300000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 445300000.00
DRX.L balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -300000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -300000.00
DRX.L income_statement (annual, 2024-12-31) — Amortization: 17000000.00
DRX.L cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 17000000.00
DRX.L income_statement (annual, 2024-12-31) — Basic Average Shares: 383200000.00
DRX.L income_statement (annual, 2024-12-31) — Basic EPS: 1.38
DRX.L cash_flow (annual, 2024-12-31) — Beginning Cash Position: 379500000.00
DRX.L balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 48100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 48100000.00
DRX.L cash_flow (annual, 2024-12-31) — Capital Expenditure: -387500000.00
DRX.L balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 116500000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 166400000.00
DRX.L balance_sheet (annual, 2024-12-31) — Capital Stock: 49400000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Capital Stock: 49400000.00
DRX.L balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 356000000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 356000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 356000000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 356000000.00
DRX.L cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -93500000.00
DRX.L cash_flow (annual, 2024-12-31) — Change In Inventory: 25200000.00
DRX.L cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -164100000.00
DRX.L cash_flow (annual, 2024-12-31) — Change In Payable: -142700000.00
DRX.L cash_flow (annual, 2024-12-31) — Change In Receivables: 392200000.00
DRX.L cash_flow (annual, 2024-12-31) — Change In Working Capital: 122100000.00
DRX.L cash_flow (annual, 2024-12-31) — Changes In Cash: -22000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Common Stock: 49400000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Common Stock: 49400000.00
DRX.L cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -93500000.00
DRX.L balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2077300000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 2077300000.00
DRX.L cash_flow (annual, 2024-12-31) — Common Stock Issuance: 2700000.00
DRX.L cash_flow (annual, 2024-12-31) — Common Stock Payments: -115400000.00
DRX.L balance_sheet (annual, 2024-12-31) — Construction In Progress: 712400000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 712400000.00
DRX.L income_statement (annual, 2024-12-31) — Cost Of Revenue: 4286000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Current Assets: 1843900000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Current Assets: 1843900000.00
DRX.L balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 26000000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 26000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Current Debt: 119000000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Current Debt: 119000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 145000000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 145000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Current Liabilities: 1535000000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 1535000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Current Provisions: 20200000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Current Provisions: 20200000.00
DRX.L cash_flow (annual, 2024-12-31) — Deferred Tax: 225900000.00
DRX.L balance_sheet (annual, 2024-12-31) — Defined Pension Benefit: 24700000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Defined Pension Benefit: 24700000.00
DRX.L cash_flow (annual, 2024-12-31) — Depreciation: 224800000.00
DRX.L cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 241800000.00
DRX.L income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 241800000.00
DRX.L income_statement (annual, 2024-12-31) — Depreciation Income Statement: 224800000.00
DRX.L balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 262200000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 262200000.00
DRX.L income_statement (annual, 2024-12-31) — Diluted Average Shares: 390652819.00
DRX.L income_statement (annual, 2024-12-31) — Diluted EPS: 1.35
DRX.L income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 526600000.00
DRX.L income_statement (annual, 2024-12-31) — EBIT: 860300000.00
DRX.L income_statement (annual, 2024-12-31) — EBITDA: 1102100000.00
DRX.L cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -1500000.00
DRX.L cash_flow (annual, 2024-12-31) — End Cash Position: 356000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Financial Assets: 81700000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Financial Assets: 81700000.00
DRX.L cash_flow (annual, 2024-12-31) — Financing Cash Flow: -491600000.00
DRX.L balance_sheet (annual, 2024-12-31) — Finished Goods: 244700000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Finished Goods: 244700000.00
DRX.L cash_flow (annual, 2024-12-31) — Free Cash Flow: 472000000.00
DRX.L cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -89300000.00
DRX.L cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 11200000.00
DRX.L balance_sheet (annual, 2024-12-31) — Goodwill: 415100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Goodwill: 415100000.00
DRX.L balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 483200000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 483200000.00
DRX.L balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 105700000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 105700000.00
DRX.L balance_sheet (annual, 2024-12-31) — Gross PPE: 5216700000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Gross PPE: 2902900000.00
DRX.L income_statement (annual, 2024-12-31) — Gross Profit: 1876500000.00
DRX.L balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 175600000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 175600000.00
DRX.L income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 14400000.00
DRX.L income_statement (annual, 2024-12-31) — Interest Expense: 107500000.00
DRX.L income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 107500000.00
DRX.L income_statement (annual, 2024-12-31) — Interest Income: 20100000.00
DRX.L income_statement (annual, 2024-12-31) — Interest Income Non Operating: 18400000.00
DRX.L cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -99500000.00
DRX.L cash_flow (annual, 2024-12-31) — Interest Received Cfo: 17500000.00
DRX.L balance_sheet (annual, 2024-12-31) — Inventory: 302000000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Inventory: 302000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Invested Capital: 3204100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Invested Capital: 3204100000.00
DRX.L cash_flow (annual, 2024-12-31) — Investing Cash Flow: -389900000.00
DRX.L cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 2700000.00
DRX.L cash_flow (annual, 2024-12-31) — Issuance Of Debt: 731800000.00
DRX.L balance_sheet (annual, 2024-12-31) — Land And Improvements: 514100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 514100000.00
DRX.L balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 140400000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 90500000.00
DRX.L balance_sheet (annual, 2024-12-31) — Long Term Debt: 1007800000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 1007800000.00
DRX.L balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1148200000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1148200000.00
DRX.L cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 731800000.00
DRX.L cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -949200000.00
DRX.L balance_sheet (annual, 2024-12-31) — Long Term Provisions: 75700000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 75700000.00
DRX.L balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 3942100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 3942100000.00
DRX.L balance_sheet (annual, 2024-12-31) — Minority Interest: 9800000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Minority Interest: 9800000.00
DRX.L income_statement (annual, 2024-12-31) — Minority Interests: 1100000.00
DRX.L cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -2900000.00
DRX.L cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -112700000.00
DRX.L balance_sheet (annual, 2024-12-31) — Net Debt: 820700000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Net Debt: 770800000.00
DRX.L cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -21900000.00
DRX.L income_statement (annual, 2024-12-31) — Net Income: 526600000.00
DRX.L income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 526600000.00
DRX.L income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 525500000.00
DRX.L income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 526600000.00
DRX.L income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 526600000.00
DRX.L cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 525500000.00
DRX.L income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 525500000.00
DRX.L cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -7700000.00
DRX.L income_statement (annual, 2024-12-31) — Net Interest Income: -88500000.00
DRX.L cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -217400000.00
DRX.L cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -217400000.00
DRX.L income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -88500000.00
DRX.L cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -40600000.00
DRX.L balance_sheet (annual, 2024-12-31) — Net PPE: 2902900000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Net PPE: 2902900000.00
DRX.L cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -379300000.00
DRX.L balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1594100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 1594100000.00
DRX.L balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 48600000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 48600000.00
DRX.L balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 280400000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 280400000.00
DRX.L income_statement (annual, 2024-12-31) — Normalized EBITDA: 1155400000.00
DRX.L income_statement (annual, 2024-12-31) — Normalized Income: 563803400.00
DRX.L cash_flow (annual, 2024-12-31) — Operating Cash Flow: 859500000.00
DRX.L income_statement (annual, 2024-12-31) — Operating Income: 914100000.00
DRX.L income_statement (annual, 2024-12-31) — Operating Revenue: 6162500000.00
DRX.L balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 369925794.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 369925794.00
DRX.L balance_sheet (annual, 2024-12-31) — Other Current Assets: 540000000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 540000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 68100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 68100000.00
DRX.L cash_flow (annual, 2024-12-31) — Other Non Cash Items: 89100000.00
DRX.L income_statement (annual, 2024-12-31) — Other Operating Expenses: 397800000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Other Payable: 264400000.00
DRX.L balance_sheet (annual, 2024-12-31) — Other Properties: 2902900000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Other Properties: 2902900000.00
DRX.L balance_sheet (annual, 2024-12-31) — Other Receivables: 340000000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Other Receivables: 340000000.00
DRX.L income_statement (annual, 2024-12-31) — Other Special Charges: -1100000.00
DRX.L income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
DRX.L balance_sheet (annual, 2024-12-31) — Payables: 408800000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Payables: 408800000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 24900000.00
DRX.L income_statement (annual, 2024-12-31) — Pretax Income: 753400000.00
DRX.L balance_sheet (annual, 2024-12-31) — Properties: 0.00
DRX.L cash_flow (annual, 2024-12-31) — Purchase Of Business: -2900000.00
DRX.L cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -7700000.00
DRX.L cash_flow (annual, 2024-12-31) — Purchase Of PPE: -379800000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Raw Materials: 57300000.00
DRX.L income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 4286000000.00
DRX.L income_statement (annual, 2024-12-31) — Reconciled Depreciation: 241800000.00
DRX.L cash_flow (annual, 2024-12-31) — Repayment Of Debt: -949200000.00
DRX.L cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -115400000.00
DRX.L balance_sheet (annual, 2024-12-31) — Retained Earnings: 1118100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 1118100000.00
DRX.L cash_flow (annual, 2024-12-31) — Sale Of PPE: 500000.00
DRX.L balance_sheet (annual, 2024-12-31) — Share Issued: 427770766.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Share Issued: 427770766.00
DRX.L income_statement (annual, 2024-12-31) — Special Income Charges: -53300000.00
DRX.L cash_flow (annual, 2024-12-31) — Stock Based Compensation: 14000000.00
DRX.L balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2077300000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 2077300000.00
DRX.L balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1594100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 1594100000.00
DRX.L income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -16096600.00
DRX.L income_statement (annual, 2024-12-31) — Tax Provision: 227900000.00
DRX.L income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.30
DRX.L balance_sheet (annual, 2024-12-31) — Taxes Receivable: 0.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 0.00
DRX.L cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -193600000.00
DRX.L balance_sheet (annual, 2024-12-31) — Total Assets: 5388600000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Total Assets: 5388600000.00
DRX.L balance_sheet (annual, 2024-12-31) — Total Capitalization: 3135000000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 3085100000.00
DRX.L balance_sheet (annual, 2024-12-31) — Total Debt: 1293200000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Total Debt: 1293200000.00
DRX.L balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2087100000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 2087100000.00
DRX.L income_statement (annual, 2024-12-31) — Total Expenses: 5248400000.00
DRX.L balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3301500000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 3301500000.00
DRX.L balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 3544700000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 3544700000.00
DRX.L balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1766500000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1766500000.00
DRX.L income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 850200000.00
DRX.L income_statement (annual, 2024-12-31) — Total Other Finance Cost: 600000.00
DRX.L balance_sheet (annual, 2024-12-31) — Total Tax Payable: 9600000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 9600000.00
DRX.L income_statement (annual, 2024-12-31) — Total Unusual Items: -53300000.00
DRX.L income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -53300000.00
DRX.L balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 57844972.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 57844972.00
DRX.L balance_sheet (annual, 2024-12-31) — Treasury Stock: 314200000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 314200000.00
DRX.L balance_sheet (annual, 2024-12-31) — Working Capital: 308900000.00
DRX.L balance_sheet (quarterly, 2024-12-31) — Working Capital: 308900000.00
DRX.L income_statement (annual, 2024-12-31) — Write Off: 40000000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 344300000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 447200000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 153000000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Capital Stock: 49800000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 276000000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 276000000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Common Stock: 49800000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Current Assets: 1905300000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Current Debt: 290500000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1873300000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 119200000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Inventory: 269300000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3137600000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 858300000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 987300000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 73000000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Net Debt: 872800000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Net PPE: 2784400000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1522400000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 47200000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 275300000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 896500000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Other Properties: 2784400000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Payables: 1340700000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1291800000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Share Issued: 431514255.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1522400000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Total Assets: 5268900000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2847100000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1401700000.00
DRX.L balance_sheet (quarterly, 2025-06-30) — Working Capital: 32000000.00
DRX.L income_statement (annual, 2025-12-31) — +Operating Expense: 881000000.00
DRX.L income_statement (annual, 2025-12-31) — +Total Revenue: 5390700000.00
DRX.L balance_sheet (annual, 2025-12-31) — Accounts Payable: 150700000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 150700000.00
DRX.L balance_sheet (annual, 2025-12-31) — Accounts Receivable: 26900000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 26900000.00
DRX.L balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -2794000000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2794000000.00
DRX.L balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 450000000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 450000000.00
DRX.L income_statement (annual, 2025-12-31) — Amortization: 14200000.00
DRX.L cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 14200000.00
DRX.L income_statement (annual, 2025-12-31) — Basic Average Shares: 352800000.00
DRX.L income_statement (annual, 2025-12-31) — Basic EPS: 0.21
DRX.L cash_flow (annual, 2025-12-31) — Beginning Cash Position: 356000000.00
DRX.L balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 51100000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 51100000.00
DRX.L cash_flow (annual, 2025-12-31) — Capital Expenditure: -294200000.00
DRX.L balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 148700000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 148700000.00
DRX.L balance_sheet (annual, 2025-12-31) — Capital Stock: 49900000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Capital Stock: 49900000.00
DRX.L balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 302100000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 302100000.00
DRX.L balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 302100000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 302100000.00
DRX.L cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -95700000.00
DRX.L balance_sheet (annual, 2025-12-31) — Cash Equivalents: 206600000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 206600000.00
DRX.L balance_sheet (annual, 2025-12-31) — Cash Financial: 95500000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Cash Financial: 95500000.00
DRX.L cash_flow (annual, 2025-12-31) — Change In Inventory: 76500000.00
DRX.L cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -26600000.00
DRX.L cash_flow (annual, 2025-12-31) — Change In Payable: -110200000.00
DRX.L cash_flow (annual, 2025-12-31) — Change In Receivables: 136200000.00
DRX.L cash_flow (annual, 2025-12-31) — Change In Working Capital: 86300000.00
DRX.L cash_flow (annual, 2025-12-31) — Changes In Cash: -56100000.00
DRX.L balance_sheet (annual, 2025-12-31) — Common Stock: 49900000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Common Stock: 49900000.00
DRX.L cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -95700000.00
DRX.L balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1713200000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1713200000.00
DRX.L cash_flow (annual, 2025-12-31) — Common Stock Issuance: 5000000.00
DRX.L cash_flow (annual, 2025-12-31) — Common Stock Payments: -221100000.00
DRX.L balance_sheet (annual, 2025-12-31) — Construction In Progress: 821900000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 821900000.00
DRX.L income_statement (annual, 2025-12-31) — Cost Of Revenue: 3877800000.00
DRX.L balance_sheet (annual, 2025-12-31) — Current Assets: 1474500000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Current Assets: 1474500000.00
DRX.L balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 28200000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 28200000.00
DRX.L balance_sheet (annual, 2025-12-31) — Current Debt: 61300000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Current Debt: 61300000.00
DRX.L balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 89500000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 89500000.00
DRX.L balance_sheet (annual, 2025-12-31) — Current Liabilities: 1372200000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1372200000.00
DRX.L balance_sheet (annual, 2025-12-31) — Current Provisions: 17600000.00
DRX.L balance_sheet (quarterly, 2025-12-31) — Current Provisions: 17600000.00
DRX.L cash_flow (annual, 2025-12-31) — Deferred Tax: 123300000.00